{
 "PrintNo":"S6045","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-03-31T11:12:57.919973Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-03-31","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1233,"Name":"Pete Harckham","Short":"HARCKHAM"}],
 "Title":"Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry",
 "Summary":"Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3343-a, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry",
 "PreviousVersions":["S4374-2017","S4482-2019"]
}